ProCE Banner Activity

Insights Into the Impact of Novel Mechanisms of Action on the Management of Schizophrenia

Slideset

Expert slides on new and emerging agents for schizophrenia including exciting new mechanisms of action, as presented at Clinical Care Options Psychopharmacology Update 2024 conference.

Released: December 03, 2024

Expiration: December 02, 2025

Share

Faculty

John M. Kane

John M. Kane, MD

Co-Director, Institute of Behavioral Science
Feinstein Institutes for Medical Research
Professor, Psychiatry and Molecular Medicine
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
New York, New York

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb